| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |